Ophthalmology Innovation Summit
Ophthalmology Innovation Summit
May 03, 2019
1 min watch

VIDEO: Aerie announces Rocklatan launch

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO At the Ophthalmology Innovation Summit, Vicente J. Anido Jr., PhD, chairman and CEO of Aerie Pharmaceuticals, discusses the market launch of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in the U.S., as well as the company’s pipeline and progress in international markets.